Cargando…

Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study

Detalles Bibliográficos
Autores principales:	Xu, Siyuan, Cheng, Jingning, Wei, Bojun, Zhang, Yang, Li, Yang, Zhang, Zongmin, Liu, Yang, Zhang, Ye, Zhang, Rui, Wang, Kai, Wang, Xiaolei, Liu, Shaoyan, Huang, Ying, Xu, Zhengang, Liu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423182/ https://www.ncbi.nlm.nih.gov/pubmed/32898320 http://dx.doi.org/10.1002/ctm2.142

Ejemplares similares

Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma
por: Huang, Hui, et al.
Publicado: (2017)

Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes
por: Xu, Siyuan, et al.
Publicado: (2021)

Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer
por: Xu, Siyuan, et al.
Publicado: (2023)

Risk stratification of lateral neck recurrence for patients with pN1a papillary thyroid cancer
por: Xu, Siyuan, et al.
Publicado: (2022)

MARCH6 promotes Papillary Thyroid Cancer development by destabilizing DHX9
por: Liu, Yang, et al.
Publicado: (2021)

Patient Age Is Significantly Related to Distant Metastasis of Papillary Thyroid Microcarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma
por: Huang, Hui, et al.
Publicado: (2023)

Efficacy of Superselective Neck Dissection in Detecting Metastasis in Patients with cN0 Papillary Thyroid Carcinoma at High Risk of Lateral Neck Metastasis
por: An, Changming, et al.
Publicado: (2017)

α-Enolase Lies Downstream of mTOR/HIF1α and Promotes Thyroid Carcinoma Progression by Regulating CST1
por: Liu, Yang, et al.
Publicado: (2021)

Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma
por: Huang, Hui, et al.
Publicado: (2022)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability
por: Hong, Shubin, et al.
Publicado: (2022)

A meta-analysis of circulating microRNAs in the diagnosis of papillary thyroid carcinoma
por: liu, Yan, et al.
Publicado: (2021)

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma
por: Teng, Huajing, et al.
Publicado: (2018)

Metastasis of papillary thyroid cancer: does body mass index (BMI) is the key factor?
por: Sun, Yuning, et al.
Publicado: (2022)

Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients
por: Zhang, Dongxue, et al.
Publicado: (2017)

Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma
por: Zhang, Yanqing, et al.
Publicado: (2017)

Preoperative prediction of extrathyroidal extension: radiomics signature based on multimodal ultrasound to papillary thyroid carcinoma
por: Wan, Fang, et al.
Publicado: (2023)

Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer
por: Xu, Weibo, et al.
Publicado: (2021)

Clinical implications of TPO and AOX1 in pediatric papillary thyroid carcinoma
por: Yu, Yongbo, et al.
Publicado: (2021)

A modified tracheal transection approach for cervical esophageal lesion treatment: A report of 13 cases
por: Liu, Yang, et al.
Publicado: (2022)

Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature
por: You, Xin, et al.
Publicado: (2018)

Discovery and identification of potential biomarkers of papillary thyroid carcinoma
por: Fan, Yuxia, et al.
Publicado: (2009)

Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
por: Chi, Yihebali, et al.
Publicado: (2023)

Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial
por: Li, Yang, et al.
Publicado: (2019)

Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer
por: Ye, Guochao, et al.
Publicado: (2023)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
por: Liu, Lina, et al.
Publicado: (2022)

Hypervascularity is more frequent in medullary thyroid carcinoma: Compared with papillary thyroid carcinoma
por: Lai, Xingjian, et al.
Publicado: (2016)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Clinical analysis of prophylactic central neck dissection for papillary thyroid carcinoma
por: Wang, Q., et al.
Publicado: (2013)

The Impact of Coexistent Hashimoto’s Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Longitudinal Genomic Evolution of Conventional Papillary Thyroid Cancer With Brain Metastasis
por: Luo, Han, et al.
Publicado: (2021)

A population-based study of the three major variants of papillary thyroid carcinoma
por: Xu, Junming, et al.
Publicado: (2021)

A prediction model for identifying high-risk lymph node metastasis in clinical low-risk papillary thyroid microcarcinoma
por: Huang, Hui, et al.
Publicado: (2023)

Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma
por: Qin, Rujia, et al.
Publicado: (2021)

Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
por: Liu, Jie, et al.
Publicado: (2017)

2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma
por: Gao, Ming, et al.
Publicado: (2017)

Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment
por: Zhang, Liang, et al.
Publicado: (2020)

Population‐based study evaluating and predicting the probability of death resulting from thyroid cancer among patients with papillary thyroid microcarcinoma
por: Wang, Kun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_16mcca27qu87k6o3etbrmbj54b